2023 Approvals
FDA Greenlights Agamree for Duchenne Muscular Dystrophy on October 26, 2023
What is Agamree prescribed for? Agamree is prescribed for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older. What is Agamree and what does it do? Agamree, pronounced ah gam' ree, (generic name: vamorolone), is a medication that was approved by the FDA